Market Insights

• Shares of Lantheus Holdings climbed significantly following Truist Securities’ upgrade from ‘Hold’ to ‘Buy,’ raising its price target from $61 to $80.
• The company’s prospects for profit re-acceleration in the fourth quarter and fiscal year 2027 are believed to be key contributors to the improved outlook.
• The reported increase in Lantheus’ shares’ intraday trading volume signals robust investor interest post-upgrade.
• The health care sector at large benefited from positive corporate updates, with Lantheus featuring prominently due to its stock surge post-assessment.